Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$64.37 - $75.65 $25,490 - $29,957
-396 Reduced 0.85%
46,180 $3.2 Million
Q4 2023

Feb 13, 2024

SELL
$46.37 - $73.65 $8,717 - $13,846
-188 Reduced 0.4%
46,576 $3.34 Million
Q3 2023

Nov 13, 2023

BUY
$52.09 - $64.1 $86,625 - $106,598
1,663 Added 3.69%
46,764 $2.44 Million
Q2 2023

Aug 04, 2023

BUY
$54.67 - $66.44 $48,273 - $58,666
883 Added 2.0%
45,101 $2.86 Million
Q1 2023

May 12, 2023

BUY
$43.8 - $56.99 $38,544 - $50,151
880 Added 2.03%
44,218 $2.39 Million
Q4 2022

Feb 10, 2023

SELL
$44.07 - $54.45 $6,963 - $8,603
-158 Reduced 0.36%
43,338 $2.29 Million
Q3 2022

Nov 14, 2022

BUY
$42.7 - $59.99 $26,260 - $36,893
615 Added 1.43%
43,496 $2.02 Million
Q2 2022

Aug 12, 2022

BUY
$43.0 - $65.64 $128,226 - $195,738
2,982 Added 7.47%
42,881 $2.45 Million
Q1 2022

May 13, 2022

BUY
$38.74 - $62.09 $90,612 - $145,228
2,339 Added 6.23%
39,899 $2.44 Million
Q4 2021

Feb 11, 2022

SELL
$35.2 - $53.42 $39,529 - $59,990
-1,123 Reduced 2.9%
37,560 $1.97 Million
Q3 2021

Nov 12, 2021

SELL
$28.72 - $42.49 $26,393 - $39,048
-919 Reduced 2.32%
38,683 $1.44 Million
Q2 2021

Aug 13, 2021

BUY
$29.3 - $44.5 $27,307 - $41,474
932 Added 2.41%
39,602 $1.62 Million
Q1 2021

May 07, 2021

BUY
$30.8 - $39.51 $3,141 - $4,030
102 Added 0.26%
38,670 $1.31 Million
Q4 2020

Feb 12, 2021

SELL
$23.34 - $32.22 $12,136 - $16,754
-520 Reduced 1.33%
38,568 $1.23 Million
Q3 2020

Nov 04, 2020

BUY
$17.61 - $31.86 $95,974 - $173,637
5,450 Added 16.2%
39,088 $1 Million
Q2 2020

Aug 12, 2020

BUY
$14.35 - $26.64 $35,028 - $65,028
2,441 Added 7.82%
33,638 $863,000
Q1 2020

May 04, 2020

BUY
$12.31 - $33.12 $40,770 - $109,693
3,312 Added 11.88%
31,197 $479,000
Q4 2019

Feb 05, 2020

SELL
$7.26 - $38.49 $1,706 - $9,045
-235 Reduced 0.84%
27,885 $957,000
Q3 2019

Nov 08, 2019

SELL
$7.47 - $14.03 $1,456 - $2,735
-195 Reduced 0.69%
28,120 $210,000
Q2 2019

Aug 13, 2019

SELL
$10.65 - $14.29 $2,630 - $3,529
-247 Reduced 0.86%
28,315 $368,000
Q1 2019

May 06, 2019

SELL
$10.9 - $14.09 $10,093 - $13,047
-926 Reduced 3.14%
28,562 $348,000
Q4 2018

Feb 13, 2019

SELL
$10.36 - $20.96 $2,351 - $4,757
-227 Reduced 0.76%
29,488 $336,000
Q3 2018

Nov 09, 2018

BUY
$17.77 - $22.9 $9,542 - $12,297
537 Added 1.84%
29,715 $645,000
Q2 2018

Aug 08, 2018

BUY
$17.33 - $23.4 $35,491 - $47,923
2,048 Added 7.55%
29,178 $516,000
Q1 2018

May 07, 2018

SELL
$15.16 - $25.49 $22,133 - $37,215
-1,460 Reduced 5.11%
27,130 $571,000
Q4 2017

Feb 09, 2018

BUY
$14.27 - $16.79 $84,977 - $99,984
5,955 Added 26.31%
28,590 $414,000
Q3 2017

Nov 09, 2017

BUY
$10.77 - $22.1 $243,778 - $500,233
22,635
22,635 $357,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.85B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.